Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer

by | Feb 5, 2026 | Clinical Trials | 0 comments

​ Conditions: Breast Cancer; Breast Cancer With Low to Intermediate HER2 Expression

Interventions: Other: DCE-MRI

Sponsors: Hao Xu

Not yet recruiting Conditions: Breast Cancer; Breast Cancer With Low to Intermediate HER2 Expression
Interventions: Other: DCE-MRI
Sponsors: Hao Xu
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *